This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_OVARY_EXALLC for full statistics.
Malignant neoplasm of ovary
C3_OVARY
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1625 |
4. Check minimum number of eventsNone |
1625 |
5. Include endpointsNone |
1625 |
6. Filter based on genotype QC (FinnGen only) |
1625 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of ovary
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1625 | 1625 | - |
| Unadjusted period prevalence (%) | 0.55 | 0.55 | - |
| Median age at first event (years) | 60.80 | 60.80 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1496
- Matched controls
- 14961
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
33.5
323.0
490
214
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
323.0
414
*
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
399.0
323.0
486
18
JAL30
NOMESCO Finland
Omentectomy
115.3
323.0
506
66
A04AA01
ATC
ondansetron; systemic, rectal
18.1
323.0
613
553
H02AB02
ATC
dexamethasone; systemic
13.9
323.0
740
986
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
+∞
323.0
431
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
962.8
323.0
818
19
A03FA01
ATC
metoclopramide; systemic, rectal
9.5
323.0
963
2392
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
240.9
323.0
405
23
128
Kela drug reimbursment
Cancers of female genital organs
194.9
323.0
877
108
JEA00
NOMESCO Finland
Appendectomy
18.2
290.0
478
376
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
24.1
264.6
389
215
B01AB10
ATC
tinzaparin; parenteral
12.5
251.1
495
569
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
+∞
246.9
230
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
15.9
245.0
424
362
WX302
NOMESCO Finland
Thoracal epidural anesthesy
15.3
225.3
395
342
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
16.1
210.1
359
288
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
454.5
203.4
199
5
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
744.0
202.3
195
*
JN4BD
NOMESCO Finland
Extensive body CT
8.3
201.6
510
873
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
10.5
197.9
423
541
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
11.2
192.4
395
466
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
16.9
191.6
319
236
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
+∞
190.8
179
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
15.1
184.8
323
268
R18
ICD-10 Finland
Ascites
28.4
174.8
242
101
JAL00
NOMESCO Finland
Biopsy of peritoneum
118.7
166.3
178
17
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
880.5
163.9
158
*
LCD00
NOMESCO Finland
Hysterectomy
8.8
159.1
373
541
L03AA13
ATC
pegfilgrastim; parenteral
11.0
152.9
312
351
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.3
150.1
864
3615
B01AB05
ATC
enoxaparin; parenteral
4.0
135.3
818
3461
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
46.6
135.2
166
40
Z51.5
ICD-10 Finland
Palliative care
9.3
128.0
286
372
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
349.9
127.5
127
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
5.4
122.1
430
1048
L03AA14
ATC
lipegfilgrastim; parenteral
16.4
113.3
188
130
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
23.0
108.4
159
77
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
64.8
108.0
125
21
8310/3-C56.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of ovary
+∞
102.3
97
*
8620/3-C56.9
ICD-O-3
Adult granulosa cell tumor of ovary of ovary
+∞
101.2
96
*
C56.74
ICD-10 Finland
Mesonephroid epithelial carcinoma of the ovary
1023.6
99.3
96
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
42.1
99.1
124
32
8470/3-C56.9
ICD-O-3
Mucinous cystadenocarcinoma, NOS, of ovary
+∞
99.1
94
*
WW500
NOMESCO Finland
Blood transfusion
10.6
98.2
200
215
C56.92
ICD-10 Finland
Malignant ovarian tumor, sex chord stroma derived
259.0
95.8
97
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
21.9
92.9
138
69
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
23.3
91.9
134
63
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
70.4
91.9
105
16
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
13.5
91.4
164
135
8460/3-C56.9
ICD-O-3
Low grade serous carcinoma of ovary
+∞
90.5
86
*
A04AA55
ATC
palonosetron, combinations; systemic
9.1
88.9
197
245
L03AA02
ATC
filgrastim; parenteral
11.2
88.9
175
175
JN4AD
NOMESCO Finland
Body CT examination
5.8
88.2
276
564
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
887.7
86.5
84
*
N02AA05
ATC
oxycodone; systemic
3.9
83.9
408
1306
JAH01
NOMESCO Finland
Laparoscopy
6.9
83.8
224
371
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
72.3
83.5
95
14
X77
ICPC
Malignant neopl genital female other
53.9
80.5
96
19
TPH07
NOMESCO Finland
Cathetrisation of artery
4.7
80.1
307
781
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
65.2
79.6
92
15
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
15.4
78.8
133
94
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
76.7
77.1
87
12
JAH00
NOMESCO Finland
Laparotomy
10.6
76.7
155
162
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
29.3
76.5
104
38
ZX120
NOMESCO Finland
Intravenous
4.5
74.0
293
765
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
115.9
71.6
77
7
A04AA03
ATC
tropisetron; systemic
43.4
69.4
86
21
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.0
67.9
306
897
JAL31
NOMESCO Finland
Laparoscopic omentectomy
46.8
65.5
80
18
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
65.7
65.1
75
12
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
7.6
64.9
159
229
3009
Kela drug reimbursment
Niraparib
172.4
63.5
66
*
C56.91
ICD-10 Finland
Malignant granulosa cell tumor in ovary
169.7
62.5
65
*
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
33.3
62.5
82
26
1510
Kela drug reimbursment
Niraparib
167.0
61.4
64
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.5
58.0
653
3523
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.3
57.8
189
396
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
3.2
57.6
351
1294
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
25.2
56.0
79
33
TJA10
NOMESCO Finland
Laparocentesis
59.7
53.9
63
11
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
12.7
53.8
98
82
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.1
53.6
154
275
A04AA02
ATC
granisetron; systemic, transdermal
4.4
51.5
204
521
1XC07
NOMESCO Finland
NA
139.9
51.1
54
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
7.3
50.5
126
185
8480/3-C56.9
ICD-O-3
Mucinous adenocarcinoma of ovary
+∞
50.3
48
*
L01XK02
ATC
niraparib; oral
137.2
50.1
53
*
Z31.5
ICD-10 Finland
Genetic counselling
5.1
49.6
167
360
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.4
48.8
121
176
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
5.4
47.5
150
300
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.1
47.2
301
1128
JMA10
NOMESCO Finland
Transabdominal total splenectomy
54.9
44.8
53
10
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
10.1
44.3
90
94
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
64.6
43.4
50
8
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
45.7
43.4
53
12
C567
ICD-10 Finland
NA
+∞
42.9
41
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
30.6
42.0
56
19
WX402
NOMESCO Finland
General anaesthesia
2.7
41.4
339
1478
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
41.1
436
2188
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
7.8
40.4
96
131
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
11.1
40.4
78
74
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
9.1
39.9
86
100
121
Kela drug reimbursment
Severe hypofunction of sexual glands
6.5
39.7
107
175
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
24.2
39.5
56
24
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
24.3
38.1
54
23
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
8.7
37.7
83
100
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
6.9
37.3
96
147
L02BG04
ATC
letrozole; oral
3.0
36.4
228
833
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
12.5
36.4
66
55
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
12.8
35.2
63
51
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
44.2
35.1
43
10
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
23.6
33.7
48
21
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
33.5
32
*
JBA10
NOMESCO Finland
Transabdominal biopsy or excision of lesion of diaphragm
75.9
33.0
37
5
JN3AD
NOMESCO Finland
Abdominal CT examination
3.3
32.8
175
569
JFB46
NOMESCO Finland
Resection of sigmoid colon
10.2
32.5
65
66
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
33.2
32.3
42
13
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
13.5
32.1
56
43
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
13.9
31.9
55
41
8102
FHL
Second look"" surgery for a malignant tumor
+∞
31.4
30
*
1511
Kela drug reimbursment
Olaparib
+∞
31.4
30
*
389
Kela drug reimbursment
Olaparib
+∞
30.3
29
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
25.4
30.2
42
17
ZXC40
NOMESCO Finland
Use of ultrasound
12.7
30.2
54
44
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
23.3
30.1
43
19
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
7.8
30.0
70
93
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.6
29.8
89
166
8000/3-C56.9
ICD-O-3
Neoplasm, malignant of ovary
+∞
29.3
28
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.7
29.2
134
386
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
11.4
28.2
53
48
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
33.5
27.8
36
11
J94.8
ICD-10 Finland
Other specified pleural conditions
9.2
27.1
57
64
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.9
27.0
90
191
JFB00
NOMESCO Finland
Partial resection of small intestine
7.3
26.3
64
91
L01XK01
ATC
olaparib; oral
+∞
26.1
25
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
25.7
239
1091
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
8.0
24.9
57
74
1XA02
NOMESCO Finland
NA
132.2
24.7
26
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
24.7
236
1089
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
6.0
24.5
69
120
D70.82
ICD-10 Finland
Drug-induced neutropenia
6.6
24.5
64
101
JFF10
NOMESCO Finland
Loop enterostomy
16.0
24.2
39
25
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.6
24.1
114
336
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
5.6
24.1
72
135
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
6.0
23.3
65
112
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.7
23.2
104
293
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
12.7
23.2
41
33
A98
ICPC
Health maint/preventive medicine
0.5
22.5
1236
13647
LAF01
NOMESCO Finland
Laparoscopic unilateral salpingo-oophorectomy
4.4
22.4
83
197
8980/3-C56.9
ICD-O-3
Carcinosarcoma, NOS, of ovary
+∞
21.9
21
*
L01XX54
ATC
[U] niraparib; oral
116.7
21.6
23
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
21.2
656
4686
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
10.0
21.1
42
43
N02AX02
ATC
tramadol; systemic, rectal
1.7
21.0
647
4616
9080/3-C56.9
ICD-O-3
Teratoma, malignant, NOS, of ovary
+∞
20.9
20
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
111.6
20.6
22
*
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
30.5
20.6
27
9
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.9
20.4
85
225
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
3.1
20.0
114
387
A06AH03
ATC
naloxegol; oral
9.8
19.9
40
42
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
9.5
19.6
40
43
JFB20
NOMESCO Finland
Ileocaecal resection
18.0
19.6
30
17
R11
ICD-10 Finland
Nausea and vomiting
2.5
19.0
163
709
8140/3-C56.9
ICD-O-3
Adenocarcinoma, NOS, of ovary
+∞
18.8
18
*
LAF17
NOMESCO Finland
Laparoscopic excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
18.8
18
*
JFB53
NOMESCO Finland
Resection of sigmoid colon with partial proctectomy
101.3
18.6
20
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
18.6
567
3992
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
5.1
18.3
58
117
JFA70
NOMESCO Finland
Suture of small intestine
22.0
18.2
26
12
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
10.5
18.2
35
34
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
18.2
149
632
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.2
17.9
96
313
L01CB01
ATC
etoposide; systemic
18.3
17.8
27
15
JFA80
NOMESCO Finland
Suture of colon
37.2
17.6
22
6
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
7.6
17.2
40
54
X81
ICPC
Genital neopl female other/unspecif
50.6
17.0
20
*
8440/3-C56.9
ICD-O-3
Cystadenocarcinoma, NOS, of ovary
+∞
16.7
16
*
8010/3-C56.9
ICD-O-3
Carcinoma, NOS, of ovary
+∞
16.7
16
*
9060/3-C56.9
ICD-O-3
Dysgerminoma of ovary
+∞
16.7
16
*
8205
FHL
Subradical ovarian malignancy removal (includes possible genital and omet removal)
+∞
16.7
16
*
K56.7
ICD-10 Finland
Ileus, unspecified
5.7
16.7
48
87
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
91.1
16.6
18
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
6.2
16.1
43
71
JAW96
NOMESCO Finland
Other operation on abdominal wall, peritoneum, mesentery or omentum
18.7
16.0
24
13
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
33.7
15.7
20
6
L01XX46
ATC
[U] olaparib; oral
+∞
15.6
15
*
R50.9
ICD-10 Finland
Fever, unspecified
2.0
15.5
209
1115
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
5.7
15.5
44
79
XX1XW
NOMESCO Finland
Extensive written report from radiologist
4.8
15.3
51
110
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
15.2
208
1114
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.7
15.1
102
388
JBA20
NOMESCO Finland
Transabdominal partial excision of diaphragm
+∞
14.6
14
*
D27.99
ICD-10 Finland
Benign tumor of the ovary (ovary), unspecified histology
9.5
14.5
29
31
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
7.2
14.3
34
48
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
4.0
14.1
56
144
KBV10
NOMESCO Finland
Removal of stent from ureter
11.5
13.8
25
22
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
7.0
13.7
33
48
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.2
13.6
51
124
JJA40
NOMESCO Finland
Excision of lesion of liver
75.8
13.6
15
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
2.2
13.4
139
659
A79
ICPC
Malignancy NOS
5.2
13.4
41
81
LEB00
NOMESCO Finland
Biopsy of vagina
3.8
13.4
57
156
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
18.4
13.4
20
11
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
13.3
393
2686
WZC30
NOMESCO Finland
Teaching
1.9
13.3
202
1126
JN4CD
NOMESCO Finland
Very extensive body CT
3.1
13.2
73
244
ZX121
NOMESCO Finland
Central venous catheter
13.9
13.2
22
16
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
40.4
13.2
16
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
15.2
13.1
21
14
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
12.9
133
632
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
6.9
12.7
31
46
JBA00
NOMESCO Finland
Transabdominal repair of diaphragm for rupture
70.5
12.6
14
*
KCH00
NOMESCO Finland
Suture of bladder
10.1
12.5
24
24
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
4.1
12.4
47
116
K56.0
ICD-10 Finland
Paralytic ileus
8.1
12.3
27
34
JFF23
NOMESCO Finland
Transversostomy
7.0
12.1
29
42
JAL96
NOMESCO Finland
Other excision of lesion of peritoneum
26.9
12.1
16
6
B03XA02
ATC
darbepoetin alfa; parenteral
4.6
11.8
40
89
HA1AA
NOMESCO Finland
X-ray mammography
1.9
11.7
182
1020
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
11.7
53
154
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.5
11.7
53
154
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.2
11.7
43
104
N02BE01
ATC
paracetamol; systemic, rectal
1.7
11.6
1304
11960
D69.5
ICD-10 Finland
Secondary thrombocytopenia
13.7
11.5
19
14
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.8
11.4
71
258
WF004
NOMESCO Finland
Palliative radiotherapy
4.8
11.4
37
79
A02BC02
ATC
pantoprazole; systemic
1.5
11.4
985
8470
SAA02
NOMESCO Finland
Basic examination of mouth
0.7
11.3
607
7470
SAA01
NOMESCO Finland
Simple examination of mouth
0.7
11.2
705
8438
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
4.7
11.1
37
81
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
11.2
11.0
20
18
JFF30
NOMESCO Finland
Other colostomy
43.6
10.9
13
*
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.8
10.8
195
1148
XW2AT
NOMESCO Finland
Cytology of deep organ with ultrasound quidance
28.2
10.7
14
5
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
4.9
10.7
34
71
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
14.3
10.5
17
12
9110/3-C56.9
ICD-O-3
Mesonephroma, malignant of ovary
+∞
10.4
10
*
9071/3-C56.9
ICD-O-3
Yolk sac tumor, NOS, of ovary
+∞
10.4
10
*
Z93.3
ICD-10 Finland
Colostomy status
7.8
10.4
23
30
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
5.0
10.4
32
65
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
5.3
10.3
30
57
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
18.9
10.3
15
8
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
4.0
10.2
40
103
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
10.0
150
831
A04AD12
ATC
aprepitant; systemic
3.3
9.7
48
150
TJF80
NOMESCO Finland
Ostomy education
7.4
9.7
22
30
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
9.1
9.5
19
21
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.9
9.5
151
853
SPAT1153
SPAT
Removal of sutures
1.5
9.4
479
3662
Z51.88
ICD-10 Finland
Other specified medical care
3.5
9.4
43
127
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
9.4
119
617
R4190
NOMESCO Finland
Nutritional therapy
3.0
9.3
51
173
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
9.2
152
870
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
9.1
160
933
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
11.5
9.1
16
14
JN3DM
NOMESCO Finland
Abdominal very extensive MRI examination with 3 Tesla magnet
36.9
9.0
11
*
RS220
NOMESCO Finland
NA
4.9
9.0
28
58
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
3.6
9.0
39
111
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
18.7
8.9
13
7
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
7.5
8.9
20
27
S18
ICPC
Laceration/cut
1.4
8.8
592
4754
SPAT1109
SPAT
Analgesia with portable analgesic pump
9.5
8.8
17
18
LWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gynaecological surgery
14.1
8.7
14
10
M01AH05
ATC
etoricoxib; oral
0.7
8.7
599
7197
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
4.5
8.6
29
66
LAE11
NOMESCO Finland
Unilateral laparoscopic oophorectomy
7.0
8.5
20
29
3AA13
NOMESCO Finland
NA
9.0
8.5
17
19
LWA00
NOMESCO Finland
Repair of wound dehiscence in gynaecological surgery
10.1
8.5
16
16
R03AC02
ATC
salbutamol; inhalant
0.7
8.5
517
6346
WC401
NOMESCO Finland
Simple antibody therapy of local recurrence of tumour
27.7
8.5
11
*
C48.19
ICD-10 Finland
Malignant tumor in specified location in peritoneum other or unspecified histlogy
27.7
8.5
11
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.5
8.4
62
253
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.1
8.3
25
50
R2110
NOMESCO Finland
Giving the first information
1.9
8.2
120
656
JFF13
NOMESCO Finland
Terminal enterostomy
14.6
8.2
13
9
C48.20
ICD-10 Finland
Malignant tumor in unspecified localization in the peritoneum without histology
33.5
8.1
10
*
Z93.2
ICD-10 Finland
Ileostomy status
10.1
8.0
15
15
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
4.4
7.9
27
62
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
0.5
7.8
63
1207
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
5.7
7.8
21
37
TLE30
NOMESCO Finland
Tamponation of vagina
8.5
7.8
16
19
1DB01
NOMESCO Finland
NA
45.2
7.7
9
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
5.9
7.7
20
34
L02BA01
ATC
tamoxifen; oral
2.0
7.6
98
514
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
3.2
7.5
37
117
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
6.2
7.5
19
31
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
8.9
7.5
15
17
LCD30
NOMESCO Finland
Radical hysterectomy
10.1
7.5
14
14
TGA30
NOMESCO Finland
Thoracocentesis
7.2
7.5
17
24
JFB43
NOMESCO Finland
Left hemicolectomy
7.2
7.5
17
24
C57.7
ICD-10 Finland
Malignant neoplasm: Other specified female genital organs
80.5
7.4
8
*
GAE03
NOMESCO Finland
Suture of chest wall
80.5
7.4
8
*
N13.1
ICD-10 Finland
Hydronephrosis with ureteral stricture, not elsewhere classified
13.4
7.4
12
9
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
7.3
126
732
SPAT1125
SPAT
Stoma care and guidance
3.5
7.3
32
93
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
9.4
7.3
14
15
B01AB04
ATC
dalteparin; parenteral
2.1
7.2
82
407
JFB30
NOMESCO Finland
Right hemicolectomy
3.6
7.2
30
84
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
0.7
7.2
341
4385
5703
FHL
Removal of lymph nodes from the retroperitoneal space
30.2
7.1
9
*
C76.3
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Pelvis
30.2
7.1
9
*
130
Kela drug reimbursment
Malignant tumour
1.9
7.1
96
511
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.7
7.1
255
3437
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
4.9
7.0
21
43
A06AD11
ATC
lactulose; oral
1.6
6.9
205
1382
TPX15
NOMESCO Finland
Removal of vascular injection port
6.4
6.9
17
27
Z01.2
ICD-10 Finland
Dental examination
0.7
6.9
363
4598
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
4.8
6.8
21
44
D82
ICPC
Teeth/gum disease
0.7
6.8
265
3530
G03AC03
ATC
levonorgestrel; systemic
0.6
6.8
79
1359
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
4.2
6.8
24
58
JFB40
NOMESCO Finland
Resection of transverse colon
11.0
6.8
12
11
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.7
6.8
521
6252
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
9.4
6.8
13
14
KA1FN
NOMESCO Finland
Isotope renography
6.1
6.8
17
28
D27.98
ICD-10 Finland
Benign tumor of the ovary (ovary), other specified histology
6.1
6.8
17
28
C78.5
ICD-10 Finland
Secondary malignant neoplasm of large intestine and rectum
40.2
6.8
8
*
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
40.2
6.8
8
*
D48.49
ICD-10 Finland
Tumor of uncertain or unknown nature in the peritoneum, of unknown origin
40.2
6.8
8
*
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
40.2
6.8
8
*
J91
ICD-10 Finland
Pleural effusion in conditions classified elsewhere
16.8
6.7
10
6
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
4.4
6.7
22
50
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
7.8
6.6
14
18
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
12.3
6.6
11
9
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
0.4
6.6
31
707
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
10.1
6.5
12
12
B03XA01
ATC
erythropoietin; parenteral
5.7
6.5
17
30
D39.12
ICD-10 Finland
Granulosa cell tumor of uncertain nature in the ovary
70.1
6.4
7
*
T80.2
ICD-10 Finland
Infections following infusion, transfusion and therapeutic injection
70.1
6.4
7
*
C48.10
ICD-10 Finland
Malignant tumor in specified location in the peritoneum without histology
70.1
6.4
7
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
7.4
6.4
14
19
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.7
6.3
390
4840
JFB50
NOMESCO Finland
Other resection of colon
8.2
6.3
13
16
T81.2
ICD-10 Finland
Accidental puncture and laceration during a procedure, not elsewhere classified
3.6
6.3
26
73
K02.1
ICD-10 Finland
Caries of dentine
0.8
6.3
511
6100
D39.13
ICD-10 Finland
Uncertain growth nature of the ovarian tumor, sex chord derived
+∞
6.3
6
*
LCC10
NOMESCO Finland
Supravaginal hysterectomy
4.3
6.2
21
49
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
6.2
42
165
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.3
6.2
28
85
G02BA03
ATC
plastic IUD with progestogen
0.5
6.1
49
935
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
8.6
6.1
12
14
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
4.4
6.0
20
46
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
10.1
6.0
11
11
Y60.0
ICD-10 Finland
Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during surgical operation
10.1
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4281824)
441
205
29.15
307.65
1.3
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
1112
1146
28.57
307.65
15.9
2.9
u/ml
148.3
63.5
3.99
1089
1103
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
617
484
19.94
307.65
1.8
1.5
pmol/l
415.2
211.1
3.29
586
476
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
157
26
66.74
285.43
6.1
1.8
ng/l
142.8
70.4
—
82
9
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
629
1631
5.66
239.80
2.0
3.8
ug/l
6.6
12.1
1.27
459
1312
(4035726)
494
1374
4.73
166.10
1.4
1.4
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
114
87
14.02
121.36
5.5
1.4
ug/l
23.2
3.1
1.39
65
71
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
113
130
9.27
91.01
1.1
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1025
6405
2.63
75.10
6.5
4.2
g/l
32.6
35.4
31.87
980
5919
(40768806) Pleura Pathology biopsy report
93
113
8.67
71.58
1.3
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
803
4547
2.51
71.40
3.0
2.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
496
2269
2.71
68.35
7.3
3.0
mmol/l
0.8
0.8
7.73
480
2079
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
196
521
4.14
66.17
2.4
3.0
u/ml
112.8
629.6
1.16
162
444
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1021
6661
2.43
63.57
5.2
3.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
638
3453
2.40
60.07
2.9
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
646
3588
2.33
56.52
4.3
4.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1097
7598
2.37
56.41
10.2
5.7
umol/l
8.8
10.6
5.37
1057
7154
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1031
12953
0.44
50.90
5.0
5.9
mmol/mol
39.8
39.7
0.04
914
11852
(3003396) Base excess in Arterial blood by calculation
347
1521
2.63
50.31
7.6
6.2
mmol/l
0.7
1.3
2.49
284
1211
(3027801) Oxygen [Partial pressure] in Arterial blood
344
1521
2.60
48.87
7.7
6.2
kpa
15.7
12.5
15.01
327
1450
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
344
1522
2.60
48.80
7.7
6.2
kpa
5.1
5.1
0.38
328
1454
(3013650) Neutrophils [#/volume] in Blood by Automated count
1145
8337
2.26
48.37
22.6
8.7
e9/l
3.6
4.0
10.32
1027
7270
(3023487) Leukocytes [#/volume] in Peritoneal fluid
51
47
11.17
47.90
1.3
2.2
e6/l
1373.6
1113.0
0.18
34
32
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1180
14001
0.43
47.01
4.2
5.2
mmol/l
2.9
2.8
1.90
1031
12722
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
47
42
11.49
45.02
1.4
2.2
e6/l
4574.0
58389.7
0.48
27
19
(3008152) Bicarbonate [Moles/volume] in Arterial blood
222
823
2.97
43.98
9.0
6.6
mmol/l
24.7
24.9
0.32
211
768
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1149
13701
0.45
43.27
3.8
4.6
mmol/l
4.9
4.8
1.44
1012
12497
(3019060) Gas panel - Arterial blood
226
862
2.88
42.45
5.4
4.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1142
13585
0.46
40.27
3.8
4.6
mmol/l
1.6
1.6
0.31
1001
12326
(3003434) Protein [Mass/volume] in Pleural fluid
80
155
5.38
39.52
1.2
1.4
g/l
39.6
31.7
5.25
75
140
(3033658) Prothrombin time (PT) actual/Normal
588
3554
2.03
37.96
4.9
3.5
%
95.7
93.4
1.63
574
3451
(3018405) Lactate [Moles/volume] in Arterial blood
148
483
3.27
36.27
5.8
3.3
mmol/l
1.3
1.3
0.14
148
478
(3032080) INR in Blood by Coagulation assay
811
5558
1.92
35.55
8.0
8.7
inr
1.2
1.2
0.37
201
1595
(3023199) Leukocytes [#/volume] in Pleural fluid
73
145
5.22
35.06
1.2
1.3
e6/l
1504.0
1630.6
0.09
56
105
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
119
346
3.63
34.91
2.1
2.3
g/l
3.6
3.6
0.00
111
332
(3044007) Cell count panel - Peritoneal fluid
39
40
9.97
33.96
1.5
2.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
269
1241
2.40
33.92
8.3
6.8
g/l
112.8
118.6
6.58
258
1201
(3028308) Erythrocytes [#/volume] in Pleural fluid
66
126
5.42
33.12
1.2
1.3
e6/l
18240.3
136607.0
1.08
41
67
(3020630) Protein [Mass/volume] in Serum or Plasma
263
1220
2.38
32.68
6.4
2.5
g/l
64.0
66.4
5.63
250
1093
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1144
13421
0.50
32.60
5.6
5.5
mu/l
2.1
2.1
0.11
1022
12200
(3020891) Body temperature
153
550
2.97
31.71
6.6
4.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
276
1324
2.31
31.68
8.1
6.5
%
97.3
95.7
3.65
266
1278
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1106
13080
0.52
31.27
3.5
4.1
mmol/l
1.3
1.3
1.14
961
11736
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1183
13688
0.50
30.99
4.5
4.8
mmol/l
5.8
5.9
0.62
1041
12337
(3042936) Bacteria identified in Isolate by Culture
350
1905
2.07
29.00
1.8
1.9
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
102
307
3.48
28.35
1.5
3.1
u/ml
379.2
1237.4
0.48
92
278
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
28
23
12.37
28.16
12.2
2.0
u/l
38.6
37.7
—
21
9
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
270
1349
2.20
27.85
1.9
2.0
g/l
0.2
0.2
3.88
253
1272
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
194
842
2.48
27.70
9.5
7.0
%
0.8
0.7
4.80
194
837
(3033799) Differential panel - Peritoneal fluid
35
42
8.49
27.06
1.2
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
56
111
5.19
26.96
1.2
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
578
3798
1.81
26.81
16.4
6.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
116
395
3.09
26.37
2.6
3.6
u/ml
0.4
0.4
0.10
61
240
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
52
99
5.39
26.17
1.1
1.3
u/l
423.3
283.2
1.94
52
94
(3014576) Chloride [Moles/volume] in Serum or Plasma
302
1659
2.01
23.97
9.2
5.7
mmol/l
104.1
104.1
0.10
296
1621
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
627
4354
1.72
23.16
7.1
2.9
u/l
34.7
32.7
0.16
603
4121
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
38
62
6.25
22.42
2.1
3.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
521
3482
1.73
21.83
1.4
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
338
1988
1.88
21.72
2.6
1.9
s
28.6
29.4
2.08
328
1921
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
988
11738
0.60
21.42
4.9
4.6
pmol/l
15.1
14.9
1.01
880
10614
(3045788) Cell count panel - Pleural fluid
50
117
4.38
19.78
1.2
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
810
6185
1.62
19.67
2.6
2.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
484
6761
0.60
19.56
2.1
2.3
nmol/l
78.1
80.7
1.21
440
5996
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
101
377
2.79
19.45
2.1
2.0
%
87.8
94.3
1.76
95
347
(3009261) Glucose [Presence] in Urine by Test strip
910
7220
1.59
18.27
5.9
4.2
estimate
0.0
0.0
1.08
171
1286
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
244
4030
0.54
17.81
1.6
1.6
mmol/l
1.5
1.3
1.62
211
3385
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
84
298
2.92
17.77
2.1
2.0
u/l
105.0
3597.2
1.94
30
129
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
620
4517
1.60
17.74
3.6
2.4
u/l
57.8
58.6
0.12
577
4109
(3000991) Gas panel - Venous blood
201
1059
2.02
17.62
8.6
6.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
896
7157
1.56
16.89
8.2
5.6
estimate
0.0
0.0
0.50
162
1281
(3014111) Lactate [Moles/volume] in Serum or Plasma
214
1171
1.95
16.81
7.7
5.4
mmol/l
1.1
1.3
1.32
209
1130
(3031040) Bacteria [#/volume] in Urine by Automated count
1150
9782
1.60
16.02
5.7
5.2
e6/l
1239.8
2935.0
0.84
25
135
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
253
1487
1.83
15.90
5.6
4.2
u/l
257.5
251.0
0.24
242
1391
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
92
367
2.60
15.57
1.4
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
32
64
5.08
15.28
1.1
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
924
10842
0.66
14.77
3.5
4.4
mm/h
17.3
13.4
7.78
833
9956
(3026008) Bacteria identified in Urine by Culture
699
5426
1.51
14.10
3.4
3.4
—
—
—
0
0
(3036489) Thrombin time
107
482
2.31
13.93
2.1
1.9
s
21.7
21.1
0.34
101
421
(3000963) Hemoglobin [Mass/volume] in Blood
1438
15206
0.53
13.74
41.4
21.7
g/l
121.8
131.2
116.53
1412
14969
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1271
11218
1.61
13.74
11.1
7.3
u/l
88.9
78.5
5.66
1214
10475
(3010813) Leukocytes [#/volume] in Blood
1438
15204
0.53
13.66
41.0
21.6
e9/l
6.7
6.6
0.63
1394
14740
(3035941) MCH [Entitic mass]
1438
15201
0.53
13.54
40.8
21.4
pg
30.2
30.2
0.06
1411
14958
(3026361) Erythrocytes [#/volume] in Blood
1438
15201
0.53
13.54
41.0
21.6
e12/l
4.1
4.4
72.76
1397
14740
(3024731) MCV [Entitic volume]
1438
15199
0.53
13.46
40.9
21.5
fl
91.8
91.2
3.57
1411
14957
(3007461) Platelets [#/volume] in Blood
1438
15197
0.53
13.38
41.0
21.6
e9/l
273.0
261.0
6.88
1399
14786
(3013826) Glucose [Moles/volume] in Serum or Plasma
972
8217
1.46
11.86
5.9
4.2
mmol/l
6.7
6.6
0.45
926
7664
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
93
429
2.24
11.47
2.4
3.8
u/ml
51.8
35.8
1.12
86
416
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
16
22
7.34
10.99
2.6
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
284
1897
1.60
10.90
1.3
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
239
1547
1.64
10.40
2.7
2.3
umol/l
7.1
6.7
0.12
203
1313
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
828
6902
1.41
10.25
6.1
5.4
mmol/l
1.2
1.2
25.78
767
6199
(3015377) Calcium [Moles/volume] in Serum or Plasma
682
5506
1.41
10.11
5.8
3.3
mmol/l
2.4
2.4
2.29
631
4743
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
174
1045
1.74
10.01
1.5
1.6
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
46
165
2.84
9.64
3.8
1.4
nmol/l
0.2
0.3
2.45
35
122
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
17
29
5.91
9.60
1.1
1.2
ug/l
1641.5
108.5
—
8
19
(1761868) Lipid panel - Serum or Plasma
324
4398
0.67
9.20
2.8
3.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
230
1540
1.57
8.64
1.6
1.7
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
62
273
2.32
8.59
5.6
7.8
mmol/l
104.3
105.0
0.41
55
245
(3039000) Anion gap in Blood
62
273
2.32
8.59
5.6
7.8
mmol/l
10.9
10.9
0.06
55
245
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
135
811
1.72
7.76
1.7
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
337
4412
0.70
7.55
3.7
3.8
mg/mmol
16.8
7.8
2.68
199
2491
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
510
6235
0.73
7.45
2.0
2.1
pmol/l
93.6
97.7
1.04
269
2861
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
114
665
1.77
7.27
11.0
8.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
877
7619
1.33
7.24
6.5
6.1
mmol/l
1.2
1.2
28.60
771
6398
(3012516) Albumin [Mass/volume] in Urine
321
4194
0.71
7.00
3.1
3.1
mg/l
543.7
368.1
0.23
187
2358
(3037467) Urinalysis macro (dipstick) panel - Urine
1105
9952
1.34
6.98
7.3
4.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
248
1764
1.48
6.98
4.5
4.6
mmol/l
1.0
1.0
0.63
232
1599
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1407
14731
0.67
6.78
19.6
10.9
u/l
23.3
23.3
0.03
1367
14145
(40761535) Cells panel - Urine sediment
182
1223
1.55
6.70
4.9
3.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
56
267
2.14
6.48
1.2
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
344
4363
0.73
6.08
2.9
3.0
mmol/l
6.1
6.2
0.16
290
3618
(3047181) Lactate [Moles/volume] in Blood
73
394
1.89
6.02
5.7
6.6
mmol/l
1.3
1.2
0.13
64
349
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
695
7988
0.77
5.99
2.5
2.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
248
3297
0.71
5.83
1.2
1.3
u/ml
0.6
1.4
3.58
64
838
(3011397) Hemoglobin [Presence] in Urine by Test strip
437
3521
1.33
5.81
6.5
4.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
73
400
1.86
5.76
2.1
2.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
465
3789
1.32
5.70
6.3
4.7
estimate
0.0
0.0
0.34
160
1288
(3009542) Hematocrit [Volume Fraction] of Blood
1144
12311
0.76
5.68
27.6
15.8
%
36.3
38.4
11.94
770
8360
(3018095) Leukocytes [#/volume] in Urine
594
5021
1.29
5.49
5.2
3.7
e6/l
117.4
104.9
0.13
403
3429
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
189
2610
0.69
5.48
1.2
1.3
u/ml
10.9
15.0
0.34
70
972
(3035350) Ketones [Presence] in Urine by Test strip
804
7082
1.27
5.24
6.3
4.1
estimate
0.0
0.0
0.00
166
1283
(3002032) Base excess in Venous blood by calculation
174
1222
1.47
5.20
3.2
3.2
mmol/l
2.5
2.1
0.62
143
1012
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
300
2322
1.36
5.16
1.7
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1247
13214
0.76
5.05
26.1
13.5
ml/min/173m2
79.0
77.2
2.22
1086
10834
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
203
2726
0.71
4.99
1.2
1.3
iu/ml
55.8
38.7
0.29
66
902
(3002582) Erythrocytes [#/volume] in Urine
500
4181
1.28
4.92
2.9
3.2
e6/l
27.4
56.9
1.72
382
3142
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
188
1359
1.43
4.84
2.1
2.2
u/l
30.7
37.4
1.21
162
1153
(3008757) Leukocyte morphology finding [Identifier] in Blood
32
138
2.35
4.77
3.0
3.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
87
533
1.67
4.74
1.6
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
210
2777
0.72
4.68
1.4
1.4
g/l
2.1
2.3
0.91
123
1552
(40761511) CBC panel - Blood by Automated count
1373
14305
0.74
4.39
23.5
13.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
236
1807
1.36
4.33
2.0
2.5
%
21.8
21.3
0.20
193
1528
(3027945) Reticulocytes/100 erythrocytes in Blood
202
1515
1.38
4.22
2.0
2.6
%
2.0
1.9
1.03
187
1318
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
42
214
1.99
4.18
1.4
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
235
1816
1.34
4.06
13.1
25.1
inr
1.1
1.3
2.08
24
237
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
246
1923
1.33
3.93
9.7
6.9
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
42
220
1.93
3.89
2.6
3.1
%
1.6
1.4
0.21
37
163
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
137
1886
0.70
3.86
3.9
4.7
%
30.3
34.0
3.45
86
1187
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
97
1424
0.66
3.84
1.6
1.7
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
11
29
3.81
3.80
1.0
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
124
871
1.46
3.75
1.5
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
247
1948
1.32
3.70
2.0
2.4
g/l
2.2
2.4
5.31
231
1786
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
88
579
1.55
3.65
1.7
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
171
2245
0.73
3.60
1.4
1.4
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
7
9
7.81
3.56
1.6
1.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
531
6049
0.82
3.49
2.5
2.8
ug/l
199.4
102.4
6.92
494
5528
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
272
2192
1.29
3.47
2.7
2.8
e6/l
4.2
4.2
0.01
143
1112
(40768797) Stomach Pathology biopsy report
166
2165
0.74
3.35
1.2
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
80
528
1.54
3.30
4.9
5.3
%
0.9
0.9
0.20
73
499
(3037121) Protein [Mass/volume] in Urine
71
456
1.58
3.29
6.8
2.9
g/l
0.1
0.3
2.37
38
147
(3019309) Folate [Moles/volume] in Red Blood Cells
230
2860
0.77
3.28
1.7
1.8
nmol/l
1208.1
1207.9
0.00
165
2076
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
80
531
1.53
3.22
4.9
5.2
%
1.8
1.5
1.49
73
500
(3000492) Spirometry study
82
1197
0.67
3.19
1.5
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
94
649
1.48
3.14
2.3
2.6
e6/l
0.2
0.4
1.13
89
626
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
93
643
1.47
3.09
3.1
2.2
%
1.3
1.1
0.63
93
637
(3019832) Treponema pallidum Ab [Presence] in Serum
46
756
0.60
3.04
1.5
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
260
2126
1.27
2.95
2.0
2.4
umol/l
13.1
12.4
0.45
249
1949
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
376
3206
1.22
2.92
1.9
1.8
mg/l
1.9
1.1
3.51
310
2468
(36304419) Bacteria [Presence] in Urine
438
3802
1.21
2.84
2.9
3.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
40
667
0.59
2.82
2.1
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
74
1074
0.67
2.82
1.2
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
39
653
0.59
2.80
1.2
1.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
726
6603
1.18
2.76
6.6
6.1
%
8.5
8.5
0.19
678
6115
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
204
1635
1.28
2.73
1.6
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
52
806
0.63
2.72
2.2
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
158
1226
1.32
2.69
3.1
3.9
%
1.6
0.9
1.96
77
307
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
187
1486
1.29
2.67
3.3
3.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
797
7322
1.17
2.64
7.0
5.8
e9/l
0.2
0.2
5.11
690
6347
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
30
162
1.87
2.63
4.5
3.2
nmol/l
3.5
38.7
0.52
30
156
(3030467) Casts [#/volume] in Urine by Automated count
446
3906
1.20
2.60
2.9
3.1
e6/l
0.5
0.5
0.02
335
2916
(3019198) Lymphocytes [#/volume] in Blood
785
7211
1.17
2.59
6.8
5.6
e9/l
1.7
1.9
8.04
683
6289
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
285
2393
1.23
2.56
2.6
2.6
e6/l
1.9
1.5
0.32
154
1308
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
202
1631
1.27
2.55
1.6
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
18
81
2.24
2.54
3.7
3.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
766
7032
1.17
2.52
6.8
5.6
e9/l
0.6
0.6
0.36
652
6013
(21494755) Public health laboratory ask at order entry panel
55
826
0.65
2.51
1.3
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
43
682
0.62
2.51
1.3
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
739
6769
1.17
2.50
6.4
5.9
%
26.0
28.3
5.58
686
6226
(3048689) Calprotectin [Mass/mass] in Stool
136
1744
0.76
2.45
1.5
2.0
ug/g
128.3
128.3
0.00
102
1332
(3004119) Hemoglobin [Mass/volume] in Venous blood
110
822
1.36
2.43
3.1
2.7
g/l
118.7
126.6
3.42
105
801
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
396
4509
0.84
2.40
2.1
2.1
u/l
141.7
179.3
1.12
368
4202
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
26
462
0.56
2.36
1.6
1.7
mg/l
8.8
3.8
0.36
17
325
(3021879) Hepatitis B virus core Ab [Presence] in Serum
106
792
1.36
2.35
1.2
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
87
1184
0.72
2.34
1.1
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
766
7060
1.16
2.34
6.8
5.6
e9/l
0.0
0.0
3.37
649
6041
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
367
3188
1.20
2.32
1.3
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
147
1155
1.30
2.31
5.9
2.5
ml/min/173m2
57.5
64.3
1.93
72
485
(3008898) HLA-B27 [Presence]
25
446
0.55
2.31
1.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
6
13
4.63
2.27
1.5
2.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
65
922
0.69
2.24
2.2
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
20
100
2.01
2.21
1.9
1.6
—
—
—
0
0
(4010399)
76
1044
0.71
2.18
1.3
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
64
901
0.70
2.13
2.1
1.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
85
624
1.38
2.12
2.9
3.3
mmol/l
24.7
24.3
0.46
75
561
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
101
1318
0.75
2.09
2.8
3.5
mmol/l
1.2
1.2
0.06
90
1136
(3052851) Hemolysis interference index of Serum or Plasma
63
440
1.45
2.08
3.1
3.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
128
1003
1.30
2.08
6.5
3.1
pmol/l
4.4
4.4
0.47
122
871
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
589
5360
1.16
2.07
6.1
4.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
47
309
1.54
2.07
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
47
309
1.54
2.07
1.2
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
20
103
1.95
2.05
1.5
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
142
1132
1.28
2.03
2.0
2.6
e9/l
73.9
71.9
0.18
86
845
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
607
0.65
1.97
2.2
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
607
0.65
1.97
2.2
2.2
g/l
7.2
7.6
0.87
32
457
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
348
0.54
1.96
1.3
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
606
0.65
1.96
2.2
2.2
g/l
3.5
3.7
0.67
32
437
(3023103) Potassium [Moles/volume] in Serum or Plasma
1417
14509
0.82
1.94
28.7
16.6
mmol/l
3.9
3.9
0.90
1387
14102
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
107
1370
0.77
1.94
2.4
3.2
ng/l
72.3
82.1
0.94
92
1144
(3004451) EKG impression Narrative
13
58
2.25
1.91
1.3
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
528
4793
1.15
1.89
6.5
5.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
344
0.55
1.89
1.2
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
158
0.38
1.88
1.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
343
3020
1.17
1.84
5.7
4.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
31
489
0.63
1.84
1.4
1.4
ug/g
250.6
296.7
0.61
16
276
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
42
620
0.67
1.83
1.6
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1415
14478
0.82
1.82
29.1
16.5
mmol/l
139.0
139.7
18.10
1385
14095
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
71
521
1.38
1.82
1.6
1.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
708
6576
1.14
1.78
6.4
5.8
%
2.3
2.8
7.00
655
6067
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
569
0.66
1.78
2.2
2.3
g/l
3.1
3.2
0.03
32
447
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
73
971
0.74
1.76
1.3
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
314
2759
1.17
1.73
2.8
2.7
mosm/kgh2o
506.9
507.9
0.03
274
2339
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
46
0.00
1.71
0.0
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
144
1177
1.25
1.70
8.4
4.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
717
6683
1.13
1.68
6.2
5.7
%
58.8
57.0
2.43
666
6178
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
571
0.68
1.65
2.2
2.2
g/l
8.8
9.9
1.33
34
482
(3000850) Epithelial cells [#/volume] in Urine
334
2969
1.16
1.59
2.4
2.6
e6/l
7.9
7.5
0.18
295
2582
(3003327) Ova and parasites identified in Stool by Light microscopy
29
447
0.64
1.58
1.4
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
39
561
0.69
1.53
1.7
1.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
27
2.60
1.51
1.6
2.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
684
6392
1.12
1.49
6.3
5.8
%
0.6
0.7
3.11
635
5897
(3017817) Protein [Mass] in Urine collected for unspecified duration
18
101
1.79
1.49
3.5
1.7
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
28
428
0.65
1.49
2.6
2.1
g/l
0.0
0.0
0.00
28
394
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
293
0.58
1.48
2.1
2.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
16
87
1.85
1.46
1.1
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
15
80
1.88
1.45
1.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
220
1.51
1.44
1.3
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
348
3131
1.14
1.40
5.3
4.7
kg/l
1.0
1.0
1.85
33
478
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
179
0.50
1.40
1.1
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
179
0.50
1.40
1.1
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
180
0.50
1.39
1.1
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
180
0.50
1.39
1.1
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
669
6268
1.11
1.36
13.4
9.3
e9/l
0.0
0.0
0.11
541
5094
(1002224) Polysomnography panel
30
441
0.67
1.34
1.1
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
40
0.00
1.32
0.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
59
446
1.34
1.32
1.1
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
150
0.46
1.31
4.0
3.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
193
0.52
1.29
1.2
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
42
302
1.40
1.28
1.2
1.4
mmol/l
58.6
58.1
0.03
31
238
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
17
99
1.72
1.27
1.6
1.5
umol/l
10.2
12.1
0.79
17
94
(3048879) Bone marrow aspiration report
8
35
2.29
1.27
1.0
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
170
1969
0.85
1.26
1.4
1.3
titre
652.8
652.8
0.00
47
437
(3026493) Urate [Moles/volume] in Serum or Plasma
311
3446
0.88
1.26
2.7
2.4
umol/l
6838.6
6097.5
0.09
275
2922
(21494434) Karyotype in Bone marrow
18
107
1.69
1.26
1.2
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
85
1051
0.80
1.24
1.9
2.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
19
2.64
1.21
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
25
165
1.52
1.18
1.3
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
95
1153
0.81
1.18
1.3
1.6
%
1.4
1.4
0.03
81
996
(3022145) Colonoscopy Study observation
141
1648
0.84
1.17
1.3
1.3
—
—
—
0
0
(4094501)
25
369
0.67
1.17
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
186
0.53
1.17
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
14
79
1.78
1.17
1.1
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
14
79
1.78
1.17
1.1
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
23
344
0.66
1.15
4.4
3.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
35
0.00
1.15
0.0
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
12
210
0.57
1.15
1.3
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
143
1222
1.19
1.15
1.2
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
28
191
1.47
1.14
1.3
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
70
874
0.79
1.13
1.3
1.2
u/ml
259.9
178.3
0.27
62
801
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
11
58
1.90
1.12
1.0
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
11
58
1.90
1.12
1.0
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
21
2.38
1.09
1.2
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
162
0.55
1.08
1.0
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
52
670
0.77
1.08
1.1
1.1
titre
—
270.6
—
0
16
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
24
349
0.68
1.06
1.5
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
45
589
0.76
1.06
1.3
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
25
170
1.48
1.05
1.3
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
171
1496
1.16
1.05
1.3
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
325
3550
0.89
1.04
1.6
1.5
nmol/l
20.1
21.8
1.32
293
2970
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
574
5398
1.10
1.04
3.5
3.7
ng/l
23.4
134.4
0.72
424
3746
(3017354) Segmented neutrophils/100 leukocytes in Blood
20
130
1.55
1.02
3.6
2.9
%
58.9
57.1
0.12
15
76
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
53
1.89
1.01
1.1
1.3
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
5
110
0.45
1.00
1.8
1.4
nmol/l
1.5
1.5
—
5
96
(3032773) Endomysium IgG Ab [Titer] in Serum
19
123
1.55
0.99
1.1
1.1
—
—
—
0
0
(4146454)
9
160
0.56
0.98
3.4
2.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
7
36
1.95
0.97
1.3
1.3
—
—
—
0
0
(3013512) EKG study
404
4345
0.91
0.96
4.4
3.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
137
1187
1.17
0.96
2.4
2.4
ug/l
3.9
5.6
1.44
119
1016
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
174
1.44
0.95
1.3
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
43
329
1.32
0.94
1.1
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
117
0.51
0.94
1.0
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
29
397
0.73
0.94
1.3
1.5
iu/ml
0.1
0.2
0.71
11
76
(3002619) Bacteria identified in Specimen by Culture
6
27
2.23
0.93
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
27
372
0.72
0.91
1.3
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
496
4662
1.09
0.90
3.0
3.7
ph
7.4
7.4
0.41
70
874
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
182
0.60
0.89
1.2
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
103
0.48
0.89
1.0
1.2
mmol/l
1.7
2.2
—
5
97
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
13
205
0.63
0.87
1.1
1.1
—
14.6
—
0
8
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
30
2.00
0.87
1.0
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
17
251
0.67
0.85
1.2
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
59
722
0.81
0.84
2.2
2.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
40
309
1.30
0.84
1.1
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
55
444
1.25
0.83
1.2
1.3
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
15
225
0.66
0.81
1.4
1.8
mmol/l
1.8
1.7
0.18
15
220
(1761482) Bacteria [#/volume] in Urine by Culture
49
391
1.26
0.81
5.3
4.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
9
149
0.60
0.79
1.2
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
48
1.67
0.78
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
71
845
0.83
0.78
2.4
2.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
98
1.54
0.78
1.0
1.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
36
462
0.77
0.78
3.3
3.1
mg/l
38.6
168.7
0.55
31
380
(3051611) Lipemic interference index of Serum or Plasma
23
165
1.40
0.78
3.4
3.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
30
394
0.76
0.77
2.7
2.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.4
—
84.5
—
0
28
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
91
1056
0.85
0.76
1.2
1.2
iu/ml
101.4
152.3
1.06
29
397
(3052592) Norovirus Ag [Presence] in Stool
5
24
2.09
0.74
1.8
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
88
1022
0.85
0.74
3.4
3.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
55
1.64
0.73
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
392
3681
1.09
0.73
5.5
3.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
37
290
1.28
0.72
3.5
3.5
%
60.6
57.5
0.56
37
290
(1617658) Protocol used for examination of sentinel lymph nodes
14
206
0.68
0.71
1.1
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
217
0.69
0.70
1.1
1.2
nmol/l
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
58
482
1.21
0.70
1.1
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
30
230
1.31
0.69
1.4
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
9
145
0.62
0.69
1.1
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
9
146
0.61
0.69
1.1
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
132
1175
1.13
0.69
3.3
4.0
%
0.3
0.1
1.78
58
284
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
24
319
0.75
0.69
1.3
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
27
1.85
0.68
1.4
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
35
276
1.27
0.67
1.4
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
154
1705
0.89
0.66
1.5
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
66
776
0.84
0.66
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
57
476
1.20
0.66
1.1
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
28
1.79
0.66
1.0
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
24
180
1.34
0.65
1.0
1.3
u/ml
140.2
117.4
—
6
37
(42529406) Shigella sp [Presence] in Stool by Culture
58
487
1.20
0.64
1.1
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
21
281
0.74
0.64
1.1
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
25
190
1.32
0.63
1.0
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
79
1.52
0.62
1.2
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
79
1.52
0.62
1.3
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
10
63
1.59
0.61
1.2
1.8
e6/l
677.8
775.1
—
5
27
(3010370) Gastrin [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.7
—
57.2
—
0
15
(3003338) MCHC [Mass/volume]
1112
11344
0.94
0.58
36.8
19.0
g/l
328.5
330.2
9.09
1097
11253
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
116
0.60
0.57
1.3
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
8
54
1.48
0.57
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
24
185
1.30
0.56
1.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
5
90
0.55
0.55
2.2
1.4
u/l
4.8
5.8
—
5
77
(3024980) IgG subclass 4 [Mass/volume] in Serum
14
194
0.72
0.55
1.9
1.7
g/l
0.4
0.7
—
9
150
(3037756) Immunofixation for Serum or Plasma
25
317
0.79
0.54
1.5
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
23
178
1.30
0.53
1.1
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
44
369
1.20
0.52
3.1
2.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
48
407
1.18
0.51
1.4
1.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
68
594
1.15
0.50
1.5
1.8
g/l
2.1
1.6
2.13
54
517
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
321
3038
1.07
0.50
3.2
2.9
mmol/l
2.5
2.5
4.30
286
2675
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
20
153
1.31
0.50
1.4
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
41
1.47
0.50
1.5
1.7
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
25
312
0.80
0.49
1.2
1.4
e6/l
808.3
584.7
0.14
18
256
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
25
312
0.80
0.49
1.1
1.3
e6/l
3.1
15.8
1.92
16
236
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
37
308
1.21
0.48
1.4
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
172
1.28
0.48
1.0
1.2
u/ml
269.9
263.4
0.03
16
107
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
23
181
1.27
0.48
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
145
1575
0.91
0.47
3.3
4.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
380
3629
1.06
0.46
2.0
2.3
mg/l
3.1
3.1
0.12
327
3062
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
13
94
1.39
0.46
2.3
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
84
0.59
0.45
1.0
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
18
138
1.31
0.45
2.2
6.1
mmol/l
8.0
7.2
0.34
13
115
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
34
406
0.83
0.45
1.3
1.3
u/ml
3.1
10.0
—
7
88
(3036481) Cortisol [Moles/volume] in Serum or Plasma
127
1384
0.91
0.45
2.8
2.1
nmol/l
467.8
373.8
3.89
119
1257
(4034850)
53
460
1.16
0.44
10.4
9.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
186
0.75
0.44
1.2
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
31
1.61
0.43
1.2
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
18
229
0.78
0.42
1.1
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
91
0.66
0.42
1.5
1.5
g/l
1.0
1.0
—
6
91
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
93
0.64
0.42
1.3
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
39
456
0.85
0.42
1.7
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(4212803)
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.1
—
19.5
—
0
15
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.0
—
0
8
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
16
0.00
0.41
0.0
3.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.5
—
658337.9
—
0
12
(3005011) Chlamydia sp Ab [Titer] in Serum
0
17
0.00
0.40
0.0
1.7
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
17
0.00
0.40
0.0
2.9
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
17
0.00
0.40
0.0
7.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
16
123
1.30
0.40
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
22
177
1.25
0.40
2.2
2.8
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
60
1.33
0.40
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
60
1.33
0.40
1.1
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
18
0.00
0.40
0.0
4.8
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
74
822
0.90
0.39
5.4
3.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
137
0.73
0.39
1.8
1.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
37
316
1.17
0.39
1.4
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
187
1.23
0.39
1.0
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
89
1.35
0.38
1.3
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
52
588
0.88
0.37
1.7
1.9
u/l
40.5
40.0
0.06
42
517
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
34
397
0.85
0.37
1.3
1.2
u/ml
1.4
3.3
—
5
46
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
20
246
0.81
0.37
1.1
1.2
nmol/l
0.7
0.7
0.06
20
234
(3044941) Cell count panel - Synovial fluid
19
235
0.81
0.37
1.1
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
14
180
0.78
0.37
1.1
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
22
180
1.23
0.36
1.2
1.2
u/ml
3.6
5.4
—
7
68
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
77
0.65
0.35
1.0
1.4
mmol/l
5.7
5.6
—
5
72
(44790049)
17
135
1.26
0.35
1.6
1.3
—
—
—
0
0
(44790047)
17
135
1.26
0.35
1.6
1.3
—
—
—
0
0
(44806118)
17
135
1.26
0.35
1.6
1.3
—
—
—
0
0
(44790048)
17
135
1.26
0.35
1.6
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
181
1.22
0.34
3.1
2.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
120
1115
1.08
0.34
3.5
4.0
%
0.0
0.4
0.54
45
241
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
14
177
0.79
0.33
1.0
1.1
u/ml
2.2
2.1
—
6
68
(3026470) Cobalt [Mass/volume] in Blood
6
87
0.69
0.33
1.5
2.0
ug/l
8.0
3.0
—
6
78
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
90
0.67
0.32
1.0
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
18
220
0.82
0.32
1.2
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
19
155
1.23
0.32
1.3
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
23
192
1.20
0.32
2.0
2.2
mg/l
18.9
23.5
—
7
46
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
52
1.35
0.31
2.6
2.8
u/ml
778.9
1232.4
—
7
52
(3015183) Erythrocyte sedimentation rate
7
52
1.35
0.31
1.4
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
24
202
1.19
0.31
1.0
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
63
571
1.11
0.31
1.2
1.4
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
7
98
0.71
0.30
1.3
1.2
u/l
27.7
20.7
—
7
84
(3003740) Influenza virus B Ag [Presence] in Specimen
13
164
0.79
0.30
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
13
164
0.79
0.30
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
11
142
0.77
0.30
1.0
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
14
174
0.80
0.29
1.1
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
185
1.19
0.29
1.4
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
28
241
1.16
0.29
1.4
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
195
0.82
0.29
1.1
1.1
u/ml
0.8
1.1
—
5
73
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
21
248
0.84
0.28
1.1
1.2
nmol/l
—
0.4
—
0
9
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
8
62
1.29
0.28
1.3
1.6
e9/l
0.1
0.2
—
8
53
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
63
1.27
0.27
1.1
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
8
65
1.23
0.27
1.3
1.6
e6/l
573.2
486.4
—
8
53
(3005570) Glucose [Moles/volume] in Urine
12
150
0.80
0.27
1.3
2.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
158
1663
0.94
0.26
1.4
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
38
338
1.13
0.26
1.8
1.5
—
—
—
0
0
(4024509)
14
171
0.82
0.26
1.5
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
267
0.86
0.26
2.4
2.4
ug/min
349.3
71.9
0.39
13
162
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
75
0.67
0.26
1.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
127
0.79
0.25
1.8
2.8
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
14
170
0.82
0.25
1.2
1.4
—
25.0
—
0
8
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
77
1.17
0.24
1.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
126
0.79
0.24
1.8
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
32
360
0.89
0.24
1.7
2.0
mg/l
10.2
12.1
0.85
27
329
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
212
0.85
0.24
1.1
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
24
275
0.87
0.23
1.0
1.4
—
—
—
0
0
(4062490)
10
125
0.80
0.23
1.4
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
125
0.80
0.23
1.0
1.6
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
7
91
0.77
0.22
1.0
1.8
%
79.1
73.6
—
7
85
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
867
8554
1.03
0.22
4.2
3.0
u/l
56.8
44.3
3.31
798
7815
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
116
1.21
0.22
1.2
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
41
1.22
0.22
1.0
1.1
%
106.6
116.3
—
5
36
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
11
0.00
0.21
0.0
20.5
—
5.2
—
0
11
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
98
1.23
0.21
1.5
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
38
344
1.11
0.21
1.2
1.2
—
952.9
—
0
17
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
9.4
—
0
5
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
6
48
1.25
0.20
1.3
1.2
g/l
0.3
0.3
—
6
38
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
49
1.23
0.20
3.0
2.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
40
365
1.10
0.19
2.7
3.3
nmol/l
0.8
0.8
0.27
29
278
(3004716) Salmonella sp identified in Stool by Organism specific culture
79
744
1.06
0.19
1.3
1.3
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
10
122
0.82
0.19
1.4
1.6
g/l
2.3
2.8
—
5
85
(3027135) IgG subclass 1 [Mass/volume] in Serum
10
122
0.82
0.19
1.4
1.6
g/l
4.6
6.8
—
5
86
(3024139) IgG subclass 3 [Mass/volume] in Serum
10
122
0.82
0.19
1.4
1.6
g/l
0.4
0.4
—
5
87
(40767503) Oxygen content in Capillary blood by calculation
25
280
0.89
0.18
2.1
2.4
%
14.8
16.0
1.02
15
129
(3028300) Cannabinoids [Presence] in Urine
21
238
0.88
0.18
1.1
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
24
213
1.13
0.18
2.0
1.3
—
—
—
0
0
(4306422)
20
175
1.14
0.18
1.2
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
59
1.19
0.18
3.0
4.8
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
21
185
1.14
0.18
1.2
1.1
u/ml
8.0
4.3
—
7
49
(3000764) Benzodiazepines [Presence] in Urine
21
237
0.88
0.17
1.1
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
92
968
0.95
0.17
5.7
2.9
e9/l
4.3
4.0
0.25
80
733
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
142
0.84
0.17
1.3
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
66
0.76
0.17
1.2
1.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
67
0.75
0.17
1.0
1.1
—
8.4
—
0
8
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
76
719
1.06
0.17
4.3
3.5
mmol/l
2.1
2.1
0.04
58
548
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
286
2791
1.03
0.16
3.6
3.7
ng/l
61.3
264.6
4.44
236
2173
(3027008) Opiates [Presence] in Urine
21
235
0.89
0.16
1.1
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
78
1.15
0.15
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
12
140
0.86
0.15
1.0
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
28
255
1.10
0.15
1.7
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
45
420
1.07
0.15
2.0
1.9
iu/l
5.9
4.7
0.39
13
142
(3004616) Nuclear Ab [Presence] in Serum
17
192
0.88
0.14
1.5
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
83
792
1.05
0.14
1.7
1.8
g/l
1.4
1.4
0.03
74
712
(3027944) Amphetamines [Presence] in Urine
21
233
0.90
0.14
1.1
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
96
0.83
0.13
2.3
2.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
128
0.86
0.13
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
113
1.15
0.13
1.0
1.1
—
—
—
0
0
(44813793)
9
106
0.85
0.13
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
109
0.82
0.13
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
109
0.82
0.13
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
109
0.82
0.13
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
110
0.82
0.13
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
110
0.82
0.13
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
110
0.82
0.13
1.2
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
996
10031
0.98
0.12
4.1
3.8
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
58
551
1.05
0.12
1.9
1.4
iu/l
33.9
34.5
0.05
45
474
(3042631) Mycobacterium sp identified in Specimen
20
181
1.11
0.12
2.3
2.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
137
0.87
0.12
2.1
1.7
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
10
116
0.86
0.12
1.2
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
116
0.86
0.12
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
18
162
1.11
0.12
1.1
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
168
0.89
0.11
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
85
818
1.04
0.11
1.2
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
73
700
1.04
0.11
14.1
7.2
mmol/l
24.0
24.5
0.72
66
648
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
105
1.14
0.11
1.3
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
434
4283
1.02
0.11
2.9
3.0
ng/l
1101.1
1281.4
0.46
383
3643
(3021901) Oxygen saturation in Capillary blood
24
221
1.09
0.11
2.4
2.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
29
270
1.08
0.10
3.1
3.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
324
3190
1.02
0.10
1.5
1.7
pmol/l
576.7
25786855.8
2.44
266
2575
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
127
1236
1.03
0.10
2.7
3.0
ng/l
123.3
194.3
3.82
115
1129
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
45
1.11
0.09
1.0
1.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
49
467
1.05
0.09
5.3
3.9
mmol/l
25.4
25.0
0.39
44
431
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
47
1.06
0.09
1.2
1.3
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
5
48
1.04
0.09
1.0
1.2
%
—
6.7
—
0
6
(3022313) Gas panel - Capillary blood
52
543
0.96
0.09
5.2
3.7
—
—
—
0
0
(3009343) pH of Capillary blood
77
745
1.04
0.08
4.2
3.6
ph
7.4
7.4
—
10
99
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
12
107
1.12
0.08
6.2
5.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
113
0.88
0.08
1.6
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
113
0.88
0.08
1.6
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
113
0.88
0.08
1.6
1.3
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
5
61
0.82
0.08
1.2
1.4
umol/l
4.0
3.8
—
5
56
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
61
0.82
0.08
1.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
61
0.82
0.08
1.0
1.4
nmol/l
124.4
133.3
—
5
61
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
5
62
0.81
0.08
2.0
2.0
—
221.5
—
0
11
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
62
0.81
0.08
1.2
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
115
1123
1.03
0.08
3.5
3.7
%
1.1
0.6
1.31
34
216
(4027681)
6
71
0.84
0.07
1.2
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
71
0.84
0.07
1.3
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
71
0.84
0.07
1.3
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
71
0.84
0.07
1.3
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
71
0.84
0.07
1.3
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
70
0.86
0.07
1.8
1.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
73
0.82
0.07
1.5
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
73
0.82
0.07
2.2
3.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
73
0.82
0.07
1.5
1.5
—
—
—
0
0
(4211845)
8
77
1.04
0.07
2.3
4.5
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
7
84
0.83
0.07
1.4
2.1
ug/l
3.5
2.2
—
7
74
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
12
132
0.91
0.06
1.5
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1388
13911
0.98
0.06
21.3
14.3
mg/l
35.6
21.6
33.82
1253
11015
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
101
0.89
0.06
1.4
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
36
345
1.04
0.06
1.1
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
27
284
0.95
0.06
1.1
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
35
365
0.96
0.06
1.1
1.1
u/ml
3.9
6.4
—
5
40
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
36
346
1.04
0.05
1.2
1.4
—
25.6
—
0
8
(3005719) IgG [Mass/volume] in Serum or Plasma
97
989
0.98
0.05
2.5
2.9
g/l
10.0
10.3
0.19
90
896
(4268621)
13
120
1.08
0.05
2.6
2.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
159
0.94
0.03
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
27
280
0.96
0.03
1.3
2.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
21
218
0.96
0.02
1.4
1.7
%
57.8
60.9
0.26
21
218
(3028707) Methadone [Presence] in Urine by Screen method
12
113
1.06
0.02
1.2
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
117
0.94
0.01
1.0
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
17
177
0.96
0.01
1.0
1.4
mosm/kgh2o
271.4
275.9
—
10
132
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
134
1.05
0.00
1.2
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
29
296
0.98
0.00
3.1
3.9
mmol/l
2.5
2.9
0.47
15
213
(3002385) Erythrocyte distribution width [Ratio]
1139
11397
1.00
0.00
32.4
17.6
%
14.5
13.8
38.37
1120
11131
(3044927) Protein electrophoresis panel - Urine
15
154
0.97
0.00
1.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
19
186
1.02
0.00
1.2
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
194
0.98
0.00
1.2
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
23
234
0.98
0.00
1.4
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
11
108
1.02
0.00
1.2
1.8
e9/l
1.2
1.2
—
6
71
(3005988) Vibrio sp identified in Specimen by Organism specific culture
19
188
1.01
0.00
1.2
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
19
192
0.99
0.00
1.2
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
34
342
0.99
0.00
1.3
1.3
miu/ml
253.1
238.8
0.06
12
148
(3010421) pH of Blood
36
358
1.01
0.00
3.4
3.7
ph
7.4
7.4
0.60
28
293
(3011288) Drugs identified in Urine by Screen method
15
151
0.99
0.00
1.7
1.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
19
191
0.99
0.00
1.2
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
20
201
0.99
0.00
1.6
1.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
19
187
1.02
0.00
1.2
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
31
315
0.98
0.00
4.8
3.1
mg/l
1.5
1.5
0.05
31
291
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
175
0.97
0.00
1.5
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
11
105
1.05
0.00
1.2
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
105
0.95
0.00
1.3
1.5
%
10.4
10.6
—
10
105
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
54
0.93
0.00
1.4
1.2
—
—
—
0
0
(3007733) Chloride [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
88.2
—
0
6
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
79
0.89
0.00
1.3
1.4
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
54
0.93
0.00
1.4
1.2
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
6
67
0.90
0.00
1.0
1.1
%
—
80.4
—
0
7
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
66
0.91
0.00
2.3
2.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
7
71
0.99
0.00
2.4
4.8
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
2.0
—
17.1
—
0
7
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
1.9
—
0
5
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
326.6
—
0
5
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
4.6
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
8.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
66
0.91
0.00
1.0
1.9
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
17.3
—
0
5
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
54
0.93
0.00
1.4
1.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
72
0.97
0.00
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
89
0.90
0.00
1.1
1.3
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758358) Immune stain study
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
7.4
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_OVARY – Malignant neoplasm of ovary
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).